![Drayton Wise](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Drayton Wise
Direktor/Vorstandsmitglied bei
IRULYA THERAPEUTICS INC.
Profil
Mr. Drayton Wise is on the Board of Directors at IRulya Therapeutics, Inc. Mr. Wise was previously employed as a Chief Commercial Officer by Insmed, Inc. He received his MBA from Emory University.
Aktive Positionen von Drayton Wise
| Unternehmen | Position | Beginn |
|---|---|---|
| IRULYA THERAPEUTICS INC. | Direktor/Vorstandsmitglied | 08.10.2026 |
Ehemalige bekannte Positionen von Drayton Wise
| Unternehmen | Position | Ende |
|---|---|---|
| INSMED INCORPORATED | Corporate Officer/Principal | 16.04.2025 |
Ausbildung von Drayton Wise
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
40
Beziehungen ersten Grades
3
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Insmed, Inc.
 Insmed, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases | Health Technology |
Emory University
 Emory University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Quince Therapeutics, Inc.
 Quince Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops drugs for the treatment of central nervous system disorders and Alzheimer’s diseases | Health Technology |
